Prescription of Sageretia hamosa Brongn Relieved Goiter through Promoted Apoptosis of Thyroid Cells via miR-511-3p and PTEN/PI3K/Akt Pathway

Goiter is thyroid enlargement, in China, Sageretia hamosa Brongn (SHB) can be used to treat goiter, but it has not been reported. Therefore, data analytics of SHB prescription on thyroid were explored in this study to provide a theoretical support for SHB in the treatment of goiter. In this study, rat in goiter model was constructed by using propylthiouracil (PTU) and treated with SHB prescription. Thyroid function about the triiodothyronine (T3), free thyroxine (T4), free triiodothyronine (FT3), free thyroxine (FT4), and thyroid-stimulating hormone (TSH) were measured by ELISA; thyroid coefficient was calculated after weighed thyroid; and HE staining was applied to assess the morphology of thyroid tissue. miRNA microarrays were employed to detect miRNA expression in thyroid tissue of rats. Expression of miR-511-3p was measured by RT-qPCR; expression of proteins (PTEN and apoptosis-related proteins) was tested by western blotting; relationship between miR-511-3p and PTEN was investigated by dual luciferase reporter gene assay; cell viability rate was determined by CCK-8; and cell cycle distribution and apoptosis rate were detected by flow cytometry. The results showed that SHB prescription ameliorated goiter and downregulated miR-511-3p. miR-511-3p targeted PTEN in thyroid cells and PTEN negatively regulated the activation of PI3K/Akt pathway. Furthermore, the inhibition of apoptosis in thyroid cells caused by the overexpression of miR-511-3p or the activation of PI3K/Akt pathway was reversed by treatment of SHB prescription, inhibition of miR-511-3p, or overexpression of PTEN. In conclusion, SHB prescription promoted apoptosis of thyroid through decreased miR-511-3p and regulated PTEN/PI3K/Akt pathway, it might suggest possible medical applications.

[1]  Weiling Li,et al.  Exploring the anti-ovarian cancer mechanisms of Hedyotis diffusa Willd and Scutellaria barbata D. Don by network pharmacological analysis and molecular docking. , 2021, Journal of ethnopharmacology.

[2]  F. Tsai,et al.  Effect of Chinese Herbal Medicine Therapy on Overall and Cancer Related Mortality in Patients With Advanced Nasopharyngeal Carcinoma in Taiwan , 2021, Frontiers in Pharmacology.

[3]  R. Ullah,et al.  The effectiveness of Hedyotis diffusa Willd extract in a mouse model of experimental autoimmune prostatitis , 2020, Andrologia.

[4]  Shu-wen Yu,et al.  Antitumor potential of Hedyotis diffusa Willd: A systematic review of bioactive constituents and underlying molecular mechanisms. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[5]  Bin Liu,et al.  A traditional Chinese medicine formula inhibits tumor growth in mice and regulates the miR-34b/c-Met/β-catenin pathway. , 2020, Journal of ethnopharmacology.

[6]  Junwen Ma,et al.  LINC02163 promotes colorectal cancer progression via miR-511-3p/AKT3 axis , 2020, Artificial cells, nanomedicine, and biotechnology.

[7]  Expression of Concern: Scutellaria barbata D. Don (SBD) protects oxygen glucose deprivation/reperfusion-induced injuries of PC12 cells by up-regulating Nrf2 , 2020, Artificial cells, nanomedicine, and biotechnology.

[8]  Kaixian Chen,et al.  A review of the ethnopharmacology, phytochemistry, pharmacology, and quality control of Scutellaria barbata D. Don. , 2020, Journal of ethnopharmacology.

[9]  M. Al-khairalla,et al.  Levothyroxine-induced liver injury followed by complete recovery upon cessation of the drug: a case report , 2019, Journal of Medical Case Reports.

[10]  M. Wan,et al.  miR-511-3p protects against cockroach allergen-induced lung inflammation by antagonizing CCL2. , 2019, JCI insight.

[11]  Chengwu Shen,et al.  Liver dysfunction induced by Levothyroxine Sodium Tablets (Euthyrox®) in a hypothyroid patient with Hashimoto's thyroiditis: case report and literature review. , 2019, Endocrine journal.

[12]  N. Leslie,et al.  Mechanisms of PTEN loss in cancer: It's all about diversity. , 2019, Seminars in cancer biology.

[13]  Chen Zhang,et al.  Do Different Species of Sargassum in Haizao Yuhu Decoction Cause Different Effects in a Rat Goiter Model? , 2019, Evidence-based complementary and alternative medicine : eCAM.

[14]  B. Corvilain,et al.  Graves' disease, multinodular goiter and subclinical hyperthyroidism. , 2019, Annales d'endocrinologie.

[15]  B. Stiles,et al.  PTEN: Tumor Suppressor and Metabolic Regulator , 2018, Front. Endocrinol..

[16]  H. Scher,et al.  Clinical implications of PTEN loss in prostate cancer , 2018, Nature Reviews Urology.

[17]  Ming Yang,et al.  Treatment of Goiter with Traditional Chinese Medicine Regimen Xing Qi Hua Ying Tang: A Clinical Study on 72 Patients with Multinodular and Diffuse Goiter. , 2018, Journal of Alternative and Complementary Medicine.

[18]  Lubo,et al.  Treatment of Goiter with Traditional Chinese Medicine Regimen Xing Qi Hua Ying Tang: A Clinical Study on 72 Patients with Multinodular and Diffuse Goiter , 2017 .

[19]  E. Kimura,et al.  MicroRNAs in thyroid development, function and tumorigenesis , 2017, Molecular and Cellular Endocrinology.

[20]  Mei Wang,et al.  MiRNA-target network analysis identifies potential biomarkers for Traditional Chinese Medicine (TCM) syndrome development evaluation in hepatitis B caused liver cirrhosis , 2017, Scientific Reports.

[21]  Yanqiong Zhang,et al.  Thyroid hormone synthesis: a potential target of a Chinese herbal formula Haizao Yuhu Decoction acting on iodine-deficient goiter , 2016, Oncotarget.

[22]  Ju-Sung Kim,et al.  Nutritional and nutraceutical characteristics of Sageretia theezans fruit , 2015, Journal of food and drug analysis.

[23]  J. Hescheler,et al.  Traditional Chinese Medicine Baicalin Suppresses mESCs Proliferation through Inhibition of miR-294 Expression , 2015, Cellular Physiology and Biochemistry.

[24]  M. Poutanen,et al.  Thyrocyte-specific Dicer1 deficiency alters thyroid follicular organization and prevents goiter development. , 2015, Endocrinology.

[25]  Hui-qin Luo,et al.  Chinese herbal medicine for subacute thyroiditis: a systematic review of randomized controlled trials. , 2014, Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan.

[26]  R. Parsons,et al.  PTEN function: the long and the short of it. , 2014, Trends in biochemical sciences.

[27]  S. Dworjanyn,et al.  Towards a better understanding of medicinal uses of the brown seaweed Sargassum in Traditional Chinese Medicine: a phytochemical and pharmacological review. , 2012, Journal of ethnopharmacology.

[28]  J. Wémeau.  Prise en charge thérapeutique des goitres , 2011 .

[29]  M. Katlic,et al.  The surgical management of goiter: Part II. Surgical treatment and results , 2011, The Laryngoscope.

[30]  J. Blumberg,et al.  Flavonoid-rich fraction from Sageretia theezans leaves scavenges reactive oxygen radical species and increases the resistance of low-density lipoprotein to oxidation. , 2009, Journal of medicinal food.

[31]  Jie Zhang,et al.  Effects of Kang-Jia-Wan, a Chinese medicinal herb officinal, on apoptosis induction in goiter of rats. , 2009, Journal of ethnopharmacology.

[32]  A. Di Cristofano,et al.  Pten loss in the mouse thyroid causes goiter and follicular adenomas: insights into thyroid function and Cowden disease pathogenesis. , 2007, Cancer research.

[33]  Y. Takaya,et al.  Novel flavonol glycoside, 7-O-methyl mearnsitrin, from Sageretia theezans and its antioxidant effect. , 2004, Journal of agricultural and food chemistry.

[34]  J. Juanes,et al.  Cell proliferation and apoptosis of thyroid follicular cells are involved in the involution of experimental non-tumoral hyperplastic goiter , 1998, Anatomy and Embryology.

[35]  S. Lamberts,et al.  Somatostatin receptors and disease: role of receptor subtypes. , 1996, Bailliere's clinical endocrinology and metabolism.